Our immune system in the fight against diseases
Shownotes
Oh, but the opponent is getting dangerously close to goal. Now it's time for the defence to show what it's made of. Exciting duel here. And… Ah, that was really close. Great performance here. Really…. Phew. The defence of the football team (maybe Braunschweig too?) just managed to prevent a goal. And thus helped the team to victory. Points. Money. Maybe a championship title? We may not get a championship title or money, but it does feel like a victory when our immune system successfully fights off a pathogen. It does this every day. Often without us realising it. But sometimes we do notice it. For example, in the form of cold symptoms, swollen lymph nodes, thick tonsils, fever or a red, swollen area. Then our body's own defence system, our immune system, is working at full speed. And this is only the case with harmless pathogens. Some pathogens are not so harmless. And some people's defences don't work so well either. Then it's a matter of life and death.
Our body is constantly exposed to new challenges - environmental changes and new pathogens. Our immune system can receive help against some of these - in the form of vaccinations or other medicines that can support our immune system in the fight against certain pathogens. However, there is still no help against some pathogens. Depending on WHO gets WHICH pathogen, it's a game of chance. Prof Kathrin de la Rosa wants to be one step ahead of the pathogens. She wants to be able to improve individual defence mechanisms in people whose immune system cannot cope with the pathogen on its own. And she is copying tricks from nature. Since 2024, she has headed the ‘Personalised Immunotherapy’ research group at the Centre for Individualised Infection Medicine - a joint institution of Hannover Medical School and the HZI.
More about research at the HZI on the web at
https://www.helmholtz-hzi.de/en/
Is this where you want to start your career?
https://www.helmholtz-hzi.de/en/career/jobs/open-positions/
If you want to learn more about germs, antibiotic resistance or diseases caused by viruses and bacteria, you can find out more on our knowledge portal:
Transkript anzeigen
00:00:00: [crowd cheering]
00:00:02: Ah, they're coming dangerously close to the goal now.
00:00:07: The defence must show what they've got.
00:00:09: Exciting tackles.
00:00:11: What a clean tactic.
00:00:13: That was really close.
00:00:15: [whistle]
00:00:16: Great performance here.
00:00:18: [whistle]
00:00:19: The defence of the football team just managed to prevent a goal
00:00:27: and thus help the team to victory.
00:00:32: Points, money, maybe a championship title.
00:00:36: We may not get a championship title or money,
00:00:39: but it does feel like a victory when our immune system
00:00:43: successfully fights off a pathogen.
00:00:46: It does this every day, often without us realising it.
00:00:50: But sometimes we do notice it in the form of cold symptoms,
00:00:54: swollen lymph nodes, thick tonsils, fever or a red swollen area.
00:01:00: This is when our body's own defence system, our immune system,
00:01:04: is working at full speed.
00:01:07: And this is only the case with harmless pathogens.
00:01:10: Some pathogens are not so harmless
00:01:13: and some people's defences don't work so well either.
00:01:16: Our body is constantly exposed to new challenges,
00:01:20: environmental changes and new pathogens.
00:01:24: Our immune system can receive help against some of these
00:01:27: in the form of vaccinations or other medicines.
00:01:30: However, there is still no help against some pathogens.
00:01:34: It's a game of chance.
00:01:36: Professor Catherine Delarosa wants to be able to improve
00:01:40: individual defence mechanisms in people whose immune system
00:01:44: cannot cope with the pathogen on its own.
00:01:48: And she is copying tricks from nature.
00:01:52: I'm sitting here in the library of the age that I am with
00:01:55: Professor Catherine Delarosa.
00:01:58: Nice to meet you.
00:01:59: Nice to meet you. It's a pleasure to be here.
00:02:02: We are talking about the immune system.
00:02:05: So do you have a metaphor for our immune system?
00:02:08: Yeah, I think sports very often works quite well
00:02:12: and here in particular football maybe.
00:02:14: Because if you in a football match it's very important
00:02:18: to have a good defence, to attack at some point.
00:02:21: And you need people or players who orchestrate the entire game.
00:02:25: And that's pretty much what happens with the immune system.
00:02:31: So also there you have different players,
00:02:33: you have different cells and that's so it works.
00:02:37: Yeah, OK, so you have a team that has to communicate
00:02:41: and work together.
00:02:43: Yeah, OK.
00:02:44: What actually happens in our body when it has to fight
00:02:48: the pathogen, bacterium or virus, for example?
00:02:52: I think it's extremely complex and it's very difficult
00:02:57: to answer shortly to that question.
00:03:01: But in general, so like as said for the football match,
00:03:06: you have diverse sections or players in the immune system
00:03:12: that take over different roles.
00:03:15: And for instance, one of those roles can be that there are cells
00:03:19: in our body that engulf and digest the pathogen that comes in.
00:03:27: These are for instance, macrophages or you have players
00:03:30: like T cells, which are really in the front line they attack.
00:03:35: Because if a virus for instance hides in the cell,
00:03:38: you need a player that takes care for that.
00:03:42: And then there is one more part of the immune system
00:03:46: that we are particularly interested in, which is the B cell.
00:03:49: And the B cell is the cell in the body that produces antibodies.
00:03:52: Yeah, and antibodies can bind to a pathogen,
00:03:55: mark it and can also activate other aspects of immune defense.
00:04:00: And yeah, this is part of what happens.
00:04:04: But as said, it's extremely complex.
00:04:05: And this is why there are so many researchers needed
00:04:07: in order to understand it.
00:04:09: Yes, so what exactly do you research as a monologist?
00:04:14: In general, so immunology is to understand what mechanisms,
00:04:20: what are the underlying mechanisms behind the response to a pathogen.
00:04:23: This is the sum, but then the devil is in the detail, right?
00:04:28: So it is about finding out what are the single aspects that matter,
00:04:34: what goes wrong, maybe at what moment can't we cope
00:04:38: with a certain pathogen.
00:04:39: And this is what immunology is about.
00:04:44: And which defense mechanisms do we have?
00:04:48: So what person do we have in our immune system?
00:04:52: You mentioned a few, but maybe you can talk a little bit more about it.
00:04:56: Maybe I can talk about the B cell because I like it so much.
00:04:58: Yes, we can of course talk about the B cell.
00:05:02: Yeah, so that's a player for an instance that is very particular.
00:05:06: And the reason why I'm so fascinated by this, the cell type is that it is extremely diverse.
00:05:14: So we have numerous millions of different V cells in our body
00:05:21: that are only slightly different.
00:05:23: And what is different about them is that they have different antibodies.
00:05:27: And it's important that we have that what we call diversity or repertoire
00:05:30: in order to have an answer to all these pathogens that are out there
00:05:35: that we can encounter.
00:05:37: And this is somewhat similar.
00:05:40: So T cells work similarly.
00:05:42: They also have this diversity.
00:05:44: But what is special about B cells is that during an immune response,
00:05:49: they can even further diversify and start to fine tune
00:05:56: or to come up with an even better solution than what was initially the case.
00:06:04: So it improves with the response.
00:06:06: This is something that fascinates me.
00:06:09: And an online portrait of the Hamilton Society,
00:06:11: you were described as an engineer of our defense system.
00:06:15: What does that actually mean?
00:06:17: This means that we are trying to build on solutions that are already present
00:06:23: in our body or in nature.
00:06:25: But we are trying to modify it in a way that it's getting better or more advanced
00:06:31: because to some extent nature is limited with the tools it has available.
00:06:36: To give you an example, something that we are investigating in the lab
00:06:40: is a mechanism that B cells use to mix antibodies with other proteins.
00:06:47: And when that very protein that they use to mix with the antibody
00:06:51: is reactive for the pathogen, that's a very fortunate situation
00:06:55: because then the antibody becomes immediately reactive
00:06:59: and can attack that very pathogen.
00:07:01: But the problem here is, or the limitation of nature,
00:07:05: is that not every protein that is bound by a pathogen is produced in a B cell.
00:07:10: But it needs to be produced in a B cell to end up in the antibody.
00:07:14: And this is where we try to help B cells to come up with better solutions.
00:07:19: So we add a few components and hope that we will provide a better solution
00:07:26: than nature is already providing.
00:07:28: Your research group is based at the Center of Individualized Infection Medicine,
00:07:34: that's the site of the HZ-IN-Hanoufa.
00:07:36: I think you can call it even personalized medicine.
00:07:40: Yes, exactly.
00:07:41: So it is about to find tailored solutions for an individual.
00:07:46: And in that particular case for infectious diseases of an individual,
00:07:49: how does this change the treatment of infections?
00:07:52: As I said, we need a tailored solution because we cannot always try to solve problems
00:07:59: by using one tool.
00:08:02: So sometimes you need to understand better what an individual provides.
00:08:07: For instance, what is the quality of an immune system?
00:08:10: Not everybody has the same immune system.
00:08:12: We know by experience that some of our friends, they are easily sick
00:08:17: and others never experience or never got a disease even when they are directly exposed to it.
00:08:23: So it is also about the quality of the immune system.
00:08:26: And I think here it's very important to understand what is the baseline
00:08:29: and what can be expected from a vaccine or a certain treatment
00:08:35: when this is given to an individual.
00:08:37: Vaccine research, you mentioned vaccines, is for some viruses very, very difficult.
00:08:44: For example, HIV, it has been going on for decades.
00:08:49: But why is it sometimes difficult?
00:08:52: This is completely different to SARS, right?
00:08:54: We had a very easy solution to that pathogen.
00:08:57: but yeah for
00:08:59: some viruses it is extremely tricky and there are a lot of reasons for that but just to highlight one
00:09:05: is viruses like HIV are extremely potent to mutate, to change and this is why the virus is always one
00:09:15: step ahead and our immune system is running behind which means that we have difficulties to find the
00:09:22: right solution because the evolution is so fast. How has the COVID-19 pandemic influenced the
00:09:30: direction of the research? It influenced us in many aspects. First of all our everyday lab work
00:09:37: changed completely from the moment we had to face the pandemic right as for any other
00:09:42: individual we had issues for instance to enter the lab to conduct our research we just started
00:09:48: so I just started my position so we were an extremely young team but of course we had the
00:09:54: tools to study antibodies and this is why I decided relatively quickly to address and try to contribute
00:10:01: to the pandemic by generating knowledge and we had some ideas here to how we could maybe improve
00:10:11: vaccines in the future so just to get it clear from the beginning so there isn't
00:10:16: an extremely good vaccine available for a SARS-CoV-2 but just working on it we had the idea that maybe
00:10:22: we can change vaccines to be even better by preventing that a vaccine interacts with our body.
00:10:32: So there are the vaccines and on the other side there you mentioned it people who get more sick
00:10:40: or heavier sick and there are people who don't get sick at all so how does your research help to
00:10:46: better understand why some people get more severe infections than others? We try to understand
00:10:53: the BESELTS right this is what I was trying to explain so sometimes BESELTS responses are not
00:11:01: proper they are not very effective and we are trying to get it right so to understand where
00:11:06: are the gaps in our immune system because if you understand where you have some gaps you can try to
00:11:12: fill them and find strategies to for instance create better BESELTS and supplement them but also
00:11:18: to address how does a vaccine need to look like in order to stimulate cells to fill that very gap.
00:11:25: Which new technology is our methods do you find exciting for the future on infection research?
00:11:33: Yeah they are now very general tools that are extremely exciting that are on the rise or they
00:11:39: that were just developed one very prominent example is alpha fold this is a tool with which we
00:11:46: now can predict protein structures and of course this is a very this was an extremely important
00:11:52: development because we can now just from a sequence of a protein predict how does a protein look like
00:11:58: and when it comes to vaccine design and to many other things as well but as we are talking about
00:12:03: vaccine design it is extremely important to understand how would a protein look like when you
00:12:08: have a given sequence right and if you now make a guess how could it look like in the future and
00:12:14: how could it impact our thinking and the tools that we have available then if you combine it for
00:12:20: instance with other developments for instance quantum computing these quantum computers they can
00:12:26: tackle multiple solutions at a time right and it's another dimension of computing and this would be
00:12:33: essential for a problem like a vaccine design because you need to handle many different
00:12:39: potential designs in parallel so maybe by handling many designs in parallel you can come up with a
00:12:45: completely novel solution that would have never been possible to handle in the lab because we
00:12:50: have to perform one experiment after the other right so there I think there's a lot of yeah
00:12:56: excitement and definitely something to come and I'm yeah I'm curious yeah I hear it in your
00:13:03: voice and I can see it so is this how you see the future of personalized immunotherapy or
00:13:09: are these the breakthroughs you're expecting? Yeah this will of course also help personalize
00:13:18: medicine but there I think there's another aspect that is very important which would be the
00:13:24: discovery of new biomarkers so biomarkers are yeah markers that help us to classify patients
00:13:32: and with novel biomarkers you may have the possibility to specify better what you expect
00:13:44: from an individual with regard to a vaccine for instance or from a therapy so this could be a
00:13:53: game changer okay so certain biomarkers yeah I'm excited so I hear the the words or the words
00:14:05: green lab what does it mean? It means that labs are trying to be more aware or more careful with
00:14:16: resources and climate change is an important topic if we think the the level of resources that we use
00:14:27: or consume to do research it's insane it's really an it is an incredible amount of energy that we
00:14:37: consume if you think for instance about the samples that we need to cool down to minus 80 or even more
00:14:42: in liquid nitrogen to store them there's a lot of energy needed and plastic another topic so when
00:14:49: we are conducting our essays usually we are running it just once on a single plastic plate which means
00:14:56: that after that it goes into the trashmen we are trying to minimize that now and this is where
00:15:01: green lab sticker comes into place yeah but it is just we are on the way to become better and we
00:15:07: are trying to save what we can save and we discuss it regularly in the lab and there even now these
00:15:13: certificates that you can get and we are heading for them and I think this is something that research
00:15:18: should do in general yeah a big challenge but I think it's it's important regarding climate change
00:15:26: and the health of our planet and so of our health what interests me is how did you get into your
00:15:32: field of research and what fascinate you most to be yourselves yeah initially I was planning to
00:15:40: study something completely different and so it was biotechnology and but then yeah life happened
00:15:49: and I heard in a lecture of so of immunology and so there was a seminar series during my studies
00:15:58: and I just sit in and I was listening it happened so I fell in love with the immune system and I
00:16:05: decided to cancel my plans and follow that path and continue studying the immune system and
00:16:13: particularly BESELT yeah and it's it's your passion it's my passion definitely I can see that
00:16:20: do you perhaps have a few tips for our listeners or for me for for for everyone as as a take-home
00:16:29: message that we can do to keep ourselves healthy and our immune system or our defense our body
00:16:37: defense strong one thing is to keep the body defense strong but something that is equally
00:16:42: important is to protect ourselves from pathogens or use condoms is definitely something that I
00:16:50: would like to not advise but that I stand for as well because we are facing increasing numbers
00:16:58: the awareness especially in the younger generation is not that high anymore and I think the best you
00:17:04: can do is protect yourself HIV or sexually transmitted diseases is one part but also when
00:17:10: it comes to malaria you can try not to be bitten and cover yourself with a net right
00:17:18: yeah very simple advice but I think very useful and very true thank you for your time and for
00:17:26: there for all the information thank you it was a pleasure to be here thanks for the invitation
00:17:30: that was our first season look forward to the next one in which we will once again talk to many
00:17:40: exciting researchers about our coexistence with pathogens
00:17:43: you
00:17:44: you
00:17:44: you
00:17:45: you
00:17:45: you
00:17:47: you
00:17:47: you
00:17:48: you
00:17:49: you
00:17:50: you
00:17:50: you
00:17:52: [MUSIC]
Neuer Kommentar